LETTER TO THE EDITOR
Machine learning models for outcome prediction of Chinese uveal melanoma patients: A 15-year follow-up study
Yu-Ning Chen, Yi-Ning Wang, Meng-Xi Chen, Kai Zhang, Rong-Tian Chen, Rui Fang, Heng Wang, Hai-Han Zhang, Yi-Ning Huang, Yu Feng, Jing-Ting Luo, Yin-Jun Lan, Yue-Ming Liu, Yang Li, Wen-Bin Wei
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/9/2022 doi:10.1002/cac2.12253
LETTER TO THE EDITOR
Impact of statins on the survival of patients with cancer: a nationwide population-based cohort study in South Korea
Juhee Ahn, Sungho Won, Sanghun Lee
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/8/2022 doi:10.1002/cac2.12252
LETTER TO THE EDITOR
Association between antipsychotic agents and risk of lung cancer: a nested case-control study
Jiqing Li, Fang Tang, Shucheng Si, Fuzhong Xue
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/4/2022 doi:10.1002/cac2.12242
ORIGINAL ARTICLE
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1
Dan Wu, Yi Yang, Yiran Hou, Zifeng Zhao, Ning Liang, Peng Yuan, Tao Yang, Jinliang Xing, Jibin Li
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/4/2022 doi:10.1002/cac2.12247
ORIGINAL ARTICLE
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer
Bo Cheng, Kaikai Ding, Pengxiang Chen, Jianxiong Ji, Tao Luo, Xiaofan Guo, Wei Qiu, Chunhong Ma, Xue Meng, Jian Wang, Jinming Yu, Yuan Liu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/3/2022 doi:10.1002/cac2.12244
LETTER TO THE EDITOR
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment
Gongsheng Yuan, Yan Huang, Shu-ting Yang, Andrew Ng, Shuying Yang
Cancer Communications 2021 41: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/20/2021 doi:10.1002/cac2.12228
RESEARCH HIGHLIGHT
JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
Laura Ling Ying Tan, Quynh-Thu Le, Nancy Ying Ying Lee, Melvin Lee Kiang Chua
Cancer Communications 2021 41: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/16/2021 doi:10.1002/cac2.12248
LETTER TO THE EDITOR
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci
Jian Xu,Mayrel Palestino Dominguez,Christine Alewine
Cancer Communications 2021 41: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/8/2021 doi:10.1002/cac2.12243
LETTER TO THE EDITOR
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
Yingkuan Shao, Kailun Xu, Xi Zheng, Biting Zhou, Xiuli Zhang, Lin Wang, Yaoting Sun, Dan Li, Ting Chen, Jian Wang, Shaojun Yu, Lifeng Sun, Xiaoming Xu, Shaozhi Dai, Huanhuan Gao, Guan Ruan, Wei Liu, Xue Cai, Tiansheng Zhu, Lina Qi, Jiani Chen, Wangxiong Hu, Xingyue Weng, Yi Zhu, Xueping Xiang, Zhiyuan Hu, Jinfan Li, Lirong Chen, Jimin Shao, Shu Zheng, Tiannan Guo
Cancer Communications 2021 41: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/4/2021 doi:10.1002/cac2.12240
LETTER TO THE EDITOR
Hepatitis B virus-associated follicular lymphoma presents T-cell inflamed phenotype and response to lenalidomide
Nan Wang, Wei Qin, Zhong Zheng, Ming Zhao, Jie Xiong, Hai Fang, Rui Sun, Yichao Wang, Chen Li, Lei Dong, Xiaojian Sun, Li Wang, Pengpeng Xu, Shu Cheng, Haimin Xu, Fan Zhang, Weili Zhao
Cancer Communications 2021 41: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/1/2021 doi:10.1002/cac2.12241
